Diabetes Center Berne’s Post

🚀I'm thrilled to announce that I'll be speaking at the upcoming DIA Global Meeting, taking place in San Diego, US, between 16-20 June, on a topic that's close to my heart: Digital Biomarkers as Clinical Endpoints - The Road to Regulatory Acceptability. 💡In an era where technology and healthcare are increasingly intertwined, digital biomarkers offer groundbreaking potential to revolutionize clinical trials and patient care. This session will explore how we can harness these innovative tools to meet regulatory standards and improve health outcomes worldwide. 🔍In my speech, I'll be diving deep into the current landscape of digital biomarkers, with the focus on Europe, and exploring the path towards wider regulatory acceptance. I'll be sharing real-world examples and @Bayer’s perspective to help us navigate this exciting new frontier in clinical research. 🙏I'm especially grateful to Susan Awad and Lina AlJuburi for inviting me to share the industry insights on this critical topic. Digital biomarkers have the potential to revolutionize clinical trials, offering a more objective and efficient way to measure treatment effects. However, their regulatory acceptance is still evolving. 🌐 If you're interested in the future of clinical trials and the potential of digital biomarkers, then be sure to join the conference! I look forward to a stimulating discussion and the opportunity to connect with fellow leaders in the healthcare industry. hashtag #digitalhealth hashtag #clinicaltrials hashtag #regulatoryaffairs hashtag #globalhealthcare hashtag #digitalbiomarkers hashtag #DIA2024 https://ow.ly/XxFR50QwsWt Steve Berman – BIO, Deputy Vice President, Science and Regulatory Affairs Strategy Gul Erdemli – Novartis, Global Program Regulatory director Anindita (Annie) Saha – FDA Associate Director for Strategic Initiatives, Digital Health Center of Excellence Marwan Fathallah, President and Chief Executive Officer, DIA Global Ania Mitan, DIA Susan Benedetti, MSOL, DES, Senior Project Manager, Global Annual Meeting Maureen Lamplugh, Retired, Former Annual Meeting Program Manager, DIA Christian Rommel, Bayer AG Stefan Oelrich, Bayer AG Elena Popa, Bayer AG Antoine Manson, Bayer AG

At #ISPOREurope 2024 in Barcelona Roche France and Horiana exhibited posters on 2 hot topics: 👉 One showing that aggregated data for Matching Adjusted Indirect Comparison can provide robust evidence using Quantitative Bias analysis. This is the first time that QBA is used in MAIC. 👉 The other one describing the first results of the real world study evaluating the new #MSAS questionnaire regarding autonomy of patient suffering of multiple sclerosis.

📢 EP PerMed - the European Partnership for Personalised Medicine has launched a project database on transnational research and innovation projects in #PersonalisedMedicine funded by EP PerMed and the predecessor ERA PerMed. 🌎 The database currently lists 27 transnational research and innovation projects funded by EP PerMed under the Joint Transnational Call (JTC) 2024 and 111 projects funded by the predecessor ERA PerMed under the ERA PerMed JTCs 2018-2022. This includes a total of 430 project partners funded by 65 national and regional funding organisations. The database features an interactive map, detailed filter options to select projects – for example by funder, health or research category or project partner – and detailed project descriptions. 🔗 See all projects: https://buff.ly/40X35Hf

Adama Ibrahim, EMBA of Novo Nordisk has been attending Mobile in Clinical Trials for five years! She has noticed the industry’s shift towards a more “human-centric approach of bringing in the user’s perspective, and understanding their journey”, which is a key theme at #MobileClin2024. Learn more about Mobile in Clinical Trials 2024, the leading conference for patient technologies in research: https://lnkd.in/ggv8w76s #conference #clinicaltrials #mobiletechnology

🌟 Catch Us at Autoimmunity 2024! Our esteemed colleagues, Robin Schmalfuß and Henriette Zeuch, will be representing invent Diagnostica at the International Congress on Autoimmunity 2024 in Ljubljana, Slovenia. Join them over the next two days to delve into the latest advancements in autoimmunity. 🤝 Want to connect? Send Robin or Henriette a direct message to schedule a meeting. Let’s explore collaborative opportunities and share insights! #Autoimmunity2024 #Networking #inventDiagnostica #Diagnostics #IVD #QualityControls #HumanBiomaterials

Kristophe Diaz represented the CurePSP community at the annual Milken Institute Future of Health Summit. The conference convened the best minds in the world to confront the toughest challenges in biomedical research, rare disease research, patient engagement and more. The session, “Beyond Checkboxes: Elevating Diversity and Representativeness in Patient Engagement,” highlighted how patient organizations are transforming their approaches to ensure more inclusive and equitable research and development activities. The discussion addressed the practical challenges of pursuing diversity in patient engagement and offered insights that CurePSP will be utilizing to help drive meaningful change. By prioritizing diversity and equity, the future of rare disease research can represent all voices. #CurePSP #BecauseHopeMatters #Research #PSP #MSA #CBD

🚨 Final Call for Registration! The RE(ACT) Congress and IRDiRC Conference 2025 is just around the corner! Don’t miss your chance—regular registration and abstract submissions will close at the end of the month. 🔬 This is a vital event for the rare disease research community, offering opportunities to connect, collaborate, and participate in the #RAREvolution. 🗓️ Highlights from Our Groundbreaking Program: ➡️ Diagnosing rare diseases – from NBS to machine learning ➡️ Empowering data ➡️ ATMPs – challenges and opportunities ➡️ Impacts of rare diseases on patients, families, and society ➡️ Funding models ➡️ Drug repurposing in rare diseases ➡️ Plenary talks and a poster exhibition showcasing innovative research ...and plenty of networking opportunities! 👉 Register today and check out the complete program: https://loom.ly/npx4DUQ #RAREvolution #REACTCongress2025 #RareDiseases #OrphanDiseases #ERDERA #IRDiRC

Kicking off 2025 with a new collaboration! 💥 🤝 We are happy to announce a new collaboration between Rapidemic and the Maastricht UMC+, the national reference center for Chlamydia and Care And Public Health Research Institute (CAPHRI). The collaboration project is co-funded by PPP Subsidy awarded by Top Sector Life Sciences & Health, Health~Holland to stimulate public-private partnerships. The two groups have joined forces to fast-track the development and validation of Rapidemic’s first product for on-the-spot diagnosis of highly prevalent sexually transmitted infections. Violette Defourt, CEO Rapidemic, states « The group of Petra Wolffs at the MUMC is pioneering national and international STI research in public health and molecular diagnostics. We’re excited about the prospect of bridging excellence with innovation together, and are grateful for the trust and support of Health Holland. » #innovation #sti #health #funding Sara Foreman Aman Urazov Sander de Vos Mauro Pojmaevich Haarika Bhamidipati Alex van Belkum Esra GÜMÜŞDAL Peter Rahfeld

We start the second day of the 5th annual Consortium Meeting of DigiCare4You - A Horizon 2020 Project

Excited to share my participation in the insightful webinar titled "Navigating the Future of CRCs in Decentralized and Hybrid Trials", organized by ClinoSol Research on November 30, 2024. This insightful session provided valuable knowledge about emerging trends in clinical research coordination (CRCs) and their roles in decentralized and hybrid clinical trials. #WebinarParticipation #DecentralizedTrials #HybridTrials #ClinicalResearch #LearningOpportunity